| Literature DB >> 28443941 |
Silvia Cabral1, Cristine Bonfim2,3, Rosalira Oliveira2, Paula Oliveira4,5, Terezinha Guimarães4, Eduardo Brandão5, Ana Maria Aguiar-Santos5, Zulma Medeiros5,6.
Abstract
The aim of this study was to investigate the epidemiological characteristics, antigenic profile, perceptions, attitudes and practices of individuals who have been systematically non-compliant in mass drug administration (MDA) campaigns targeting lymphatic filariasis, in the municipality of Olinda, State of Pernambuco, Northeastern Brazil. A pretested questionnaire was used to obtain information on socioenvironmental demographics, perceptions of lymphatic filariasis and MDA, and reasons for systematic noncompliance with treatment. A rapid immunochromatographic test (ICT) was performed during the survey to screen for filariasis. It was found that the survey subjects knew about filariasis and MDA. Filariasis was identified as a disease (86.2%) and 74.4% associated it with the presence of swelling in the legs. About 80% knew about MDA, and the main source of information was healthcare workers (68.3%). For men the main reasons for systematic noncompliance with MDA were that "the individual had not received the medication" (p=0.03) and for women "the individual either feared experiencing adverse reactions". According to the ICT, the prevalence of lymphatic filariasis was 2%. The most important causes of systematic noncompliance were not receiving the drug and fear of side-effects. For successful implementation of MDA programs, good planning, educational campaigns promoting the benefits of MDA, adoption of measures to minimize the impact of adverse effects and improvement of drug distribution logistics are needed.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28443941 PMCID: PMC5436738 DOI: 10.1590/S1678-9946201759023
Source DB: PubMed Journal: Rev Inst Med Trop Sao Paulo ISSN: 0036-4665 Impact factor: 1.846
Figure 1Map of the priority areas for the elimination of filariasis.
Coverage with annual single-dose DEC in Alto da Bondade and Alto da Conquista, Olinda, Brazil
| Ano | Alto da Bondade | Alto da Conquista | ||||
|---|---|---|---|---|---|---|
|
| ||||||
| No. of eligible participants MDA | Noncompliance | Coverage (%) | No. of eligible participants MDA | Noncompliance | Coverage (%) | |
| 2007 | 6.243 | 1.020 | 86 | 7.465 | 639 | 92 |
| 2008 | 6.200 | 606 | 91 | 7.228 | 370 | 95 |
| 2009 | 6.108 | 506 | 92 | 8.027 | 533 | 94 |
| 2010 | 6.097 | 684 | 90 | 7.834 | 602 | 93 |
| 2011 | 5.336 | 318 | 94 | 5.238 | 318 | 94 |
| 2012 | 4.558 | 739 | 86 | 4.105 | 167 | 96 |
| 2013 | 3.674 | 1.662 | 69 | 5.060 | 220 | 96 |
Demographic characterization of the systematic noncompliance population with mass drug administration, Olinda, Brazil
| Demographic variables | n (%) |
|---|---|
|
| |
| Female | 65 (63.7) |
| Male | 37 (36.3) |
|
| |
| 7 – 14 | 8 (7.8) |
| 15 – 24 | 11 (10.8) |
| 25 – 64 | 53 (52.0) |
| 65 – 99 | 30 (29.4) |
|
| |
| Married | 43 (42.2) |
| Single | 30 (29.4) |
| Widowed | 19 (18.6) |
| Separated | 10 (9.8) |
|
| |
| Illiterate | 17 (16.7) |
| Incomplete primary education (years 1-5) | 33 (32.4) |
| Complete primary education (years 1-5) | 16 (15.7) |
| Incomplete primary education (years 6-9) | 11 (10.8) |
| Complete primary education (years 6-9) | 2 (1.9) |
| Incomplete secondary education | 5 (4.9) |
| Complete secondary education | 18 (17.6) |
Socioenvironmental characterization of the systematic noncompliance population with mass drug administration, Olinda, Brazil
| Socioenvironmental variables | n (%) |
|---|---|
|
| |
| Masonry with coating | 88 (86.3) |
| Masonry without coating | 14 (13.7) |
|
| |
| 1 | 9 (8.8) |
| 4 to 6 | 56 (54.9) |
| 7 or more | 37 (36.3) |
|
| |
| Rudimentary cesspits | 86 (84.3) |
| Ditch | 14 (13.7) |
| Other | 2 (2.0) |
|
| |
| General water supply network | 93 (91.3) |
| Well on the property | 3 (2.9) |
| Well outside the property | 3 (2.9) |
| Other | 3 (2.9) |
|
| |
| Collection by public services | 93 (91.2) |
| Burning | 7 (6.9) |
| Disposed of in ditches or fields | 2 (1.9) |
|
| |
| None | 2 (1.9) |
| Up to 1 minimum wage | 32 (31.4) |
| From 1 to 4 minimum wages | 68 (66.7) |
Knowledge of lymphatic filariasis and MDA, and reasons for systematic noncompliance according to sex in Alto da Bondade and Alto da Conquista, Olinda, State of Pernambuco, Brazil
| Lymphatic filariasis-related variables | n (%) | Female (%) | Male (%) |
|---|---|---|---|
|
| |||
| It is a disease that leads to swelling of the leg* | 53 (51.9) | 41 (77.4) | 12 (22.6) |
| It is a disease that leads to swelling of the leg and is transmitted by the | 16 (15.7) | 09 (56.3) | 07 (43.7) |
| It is a disease transmitted by the | 08 (7.8) | 03 (37.5) | 05 (62.5) |
| It is a disease that leads to swelling of the leg and testicles | 07 (6.8) | 03 (42.9) | 04 (57.1) |
| It is a disease | 04 (3.9) | 01 (25) | 03 (75) |
| Other (It is a disease that causes redness of the leg; Blood worm) | 05 (5.0) | 02 (40) | 03 (60) |
| Does not know how to describe it | 04 (3.9) | 03 (75) | 01 (25) |
| Did not respond | 05 (5.0) | 03 (60) | 02 (40) |
|
| |||
| Yes* | 70 (68.6) | 44 (62.9) | 26 (37.1) |
| Can be cured if treated early | 21 (30.0) | -- | -- |
| If the prescribed medication is taken correctly | 19 (27.2) | -- | -- |
| Medication plus test | 04 (5.7) | -- | -- |
| Does not know or did not respond | 26 (37.1) | -- | -- |
| Does not know* | 16 (15.7) | 11 (68.75) | 05 (31.25) |
|
| |||
|
| |||
|
| |||
|
| |||
| Yes* | 82 (80.4) | 57 (69.5) | 25 (30.5) |
| No | 20 (19.6) | 08 (40) | 12 (60) |
|
| |||
| Community health agent or other health professional | 56 (68.3) | 39 (47.6) | 17 (20.7) |
| Family member/friend/neighbor | 11 (13.4) | 8 (9.8) | 3 (3.7) |
| Media | 06 (7.3) | 4 (4.9) | 2 (2.4) |
| Flyer/advertising materials | 01 (1,2) | 0 | 1 (1.2) |
| Other | 02 (2.4) | 2 (2.4) | - |
| Does not know | 06 (7.3) | 4 (4.9) | 2 (2.4) |
|
| |||
| Mentions how the medication is distributed and/or dosage* | 32 (39.0) | 23 (71.9) | 09 (28.1) |
| Mentions that it is necessary to take the medication* | 20 (24.4) | 15 (75) | 05 (25) |
| Does not know | 16 (19.5) | 08 (50) | 08 (50) |
| Confuses the treatment with the test | 04 (4.9) | 03 (75) | 01 (25) |
| Ignored | 05 (6.1) | 03 (60) | 02 (20) |
| Other (Use of repellents) | 05 (6.1) | 05 (100) | - |
|
| |||
| Considers it beneficial to the population* | 70 (85.3) | 48 (68.6) | 22 (31.4) |
| Does not know | 06 (7.3) | 04 (66.7) | 02 (33.3) |
| Criticizes the follow-up | 03 (3.7) | 03 (100) | - |
| Other | 03 (3.7) | 02 (66.7) | 01 (33.3) |
|
| |||
|
| |||
| Yes* | 51 (62.2) | 36 (70.6) | 15 (29.4) |
| No | 16 (19.5) | 09 (56.2) | 07 (43.8) |
| Does not know | 15 (18.3) | 12 (80) | 03 (20) |
|
| |||
|
| |||
|
| |||
| Did not receive the medication/the health professional failed to deliver it* | 21 (20.6) | 07 (33.3) | 14 (66.7) |
| Fear of experiencing adverse reactions* | 26 (25.4) | 20 (76.9) | 06 (23.1) |
| Did not accept treatment because does not have the disease | 12 (11.8) | 06 (50) | 06 (50) |
| Has a preexisting condition* | 10 (9.8) | 10 (100) | - |
| Believes there are restrictions due to age | 05 (4.9) | 03 (60) | 02 (40) |
| Does not like to take drugs | 03 (2.9) | 02 (66.7) | 01 (33.3) |
| Would only take it if prescribed | 02 (2.0) | 02 (100) | - |
| Other (Fear to die; The medicine is not suitable for all cases of the disease; The medication is not suitable for children) | 18 (17.7) | 11 (66.1) | 07 (39.9) |
| Did not respond | 05 (4.9) | 03 (60) | 02 (40) |
*p < 0,05